Division of Pharmaceutical Technology and Biopharmacy
Division of Pharmaceutical Technology and Biopharmacy
Division of Pharmaceutical Technology and Biopharmacy
Prof. Dr. Dagmar Fischer
The Fischer group is focussed on the development of natural and synthetic micro- and nanocarriers for drug delivery in the field of infection, inflammation and inflammation-related diseases as well as aging. A major focus is related to biopharmaceutical test systems according to the 3R principle to investigate the life cycle of drug delivery systems and the influence of the physiological environment. Furthermore, nanosafety and safe-by-design concepts as well as quality assurance concepts are provided
Nadja Kohler sucessfully defended her PhD thesis entiteled „Austausch von Rohstoffen der lipophilen Phase und des Emulgators in halbfesten Zubereitungen zur topischen Anwendung“. Congratulations!
Wir freuen uns, Prof. Dr. Dagmar Fischer vom Department Chemie und Pharmazie der FAU am 08.01.2025 von 13:30 Uhr bis 14:30 Uhr bei uns begrüßen zu dürfen. Sie wird einen spannenden Vortrag mit dem Titel „Nano in der Pharmazie: Risiko, Perspektive oder nur Mythos?“ halten, zu dem wir sämtliche Intere...
Germany pledged to become climate neutral by 2045 with the amendment to the Climate Protection Act (Klimaschutzgesetz) and the more stringent climate protection provisions it contains. The Bavarian Climate Protection Act even stipulates that Bavaria must become climate neutral by 2040.
We support...
It is a pleasure for us to report together with our colleagues from Australia and Portugal new findings that underscore the need for innovative solutions and interdisciplinary collaboration to enhance the commercial viability and sustainability of bacterial cellulose.
For more information:
Nav...
At 22 November 2024 11 c.t. Prof. Fischer will give a lunch break seminar entiteled „Sustainability in pharmaceutical formulations“ in efs-NeW.
Further information:
Emil Fischer Graduate Programme / FAU NeW
A warm welcome to Francesca Mancusi from the University of Firenze! She joint our lab as visiting scientist for 6 months as part of her PhD thesis.
Francesca, we wish you a great and sucessfull time here in Erlangen!
We are happy to announce that Dr. Mona Mahmoud joint today the TEL-Drug Delivery project and supports the projectteam with her biological and drug delivery expertise.
We wish you a good and sucessfull start!
Gesa Waßmuth presented her latest research in the TEL-Drug Delivey Project with the title "Archaeal Tetraether Lipids as a Platform for the Oral Application of mRNA Vaccines" at the Annual Meeting of the German Society for Biomaterials, from 10-12 October in Berlin. The project is funded by the Bund...
